³Ô¹ÏÍøÕ¾

Latest therapeutics News | Page 2

Strengthening Australia-Hong Kong health and investment ties
Percheron Therapeutics announces positive preclinical data for avicursen
New CRE for Nucleic Acid Sensing boosts RNA therapeutics
UQ Recognised In Life Sciences Queensland Awards
Chimeric says first patient dosed in trial of CDH17-directed CAR-T cell therapy
Emerging UQ Researchers Secure ARC Boost
De-mystifying Targeted Removal Of Red Blood Cells
Ministry of Health, Labour and Welfare in Japan Approves Partial Change Application for Moderna’s COVID-19 mRNA Vaccine Targeting SARS-COV-2 Variant JN.1
Amplia says five patients recording sustained reduction in tumour size in trial
The Quality Use of Diagnostics, Therapeutics and Pathology (QUDTP) Program – Grant opportunities now open
Chimeric says Phase 1/2 CHM CDH17 CAR-T GMP manufacturing complete
Australia’s International Development Policy
Dan L Duncan Comprehensive Cancer Center launches Phase 1 Clinical Trial Program
Scientists unpack new information on exciting yet “ambiguous” drug receptor
WHO Director-General declares mpox outbreak a public health emergency of international concern
FDA rejects MDMA-assisted therapy for PTSD treatment – a drug researcher explains the challenges psychedelics face
Do plastics cause autism? Here’s what the latest study really says
MRFF Funding Advances Hudson Institute RNA Therapies
ANU Researchers Working To Unlock Full Potential Of RNA
ANU researchers unlocking the full potential of RNA
Improving the Design of mRNA-loaded Nanocarriers for Targeted Therapies Researchers enhance stability and bioavailability of mRNA nanocarriers using triphenylphosphonium in polymeric micelles,…
Chimeric Therapeutics says first patient enrolled in cell therapy trial
Antiretrovirals in Pregnancy Research Toolkit
Alterity Therapeutics reports positive interim data from Multiple System Atrophy trial
Scientists make breakthrough in development of fridge-free storage for vital medicines
SOTIO Enters into Multi-Target Antibody Agreement with Biocytogen to Expand ADC Pipeline
New Perth Based RNA Facility To Improve Cancer Outcomes
Leading Cancer Researcher Faces Own Diagnosis
Merz Therapeutics Closes $185M Asset Purchase Agreement with Acorda Therapeutics
Treatment that could lower blood pressure to be trialled
Indigenous Knowledge Needs To Be Recognised And Valued
Hope for children with neuroblastoma as Government provides free access to DFMO
Manchester scientists pave way for greener cancer treatments with new enzyme discovery
New Way Blood Vessel Growth Is Controlled
Discovering a new way blood vessel growth is controlled
Florey biotech spin-out secures seed investment from Curie.Bio
Amplia anounces completion of recruitment of first 26 patients in Phase 2 trial
Top Performing ASX Companies
First CEO for the Sydney-based Viral Vector Manufacturing Facility
TeraPore uses Cornell research to address virus filtration challenges
Funding available for dementia and cognitive decline innovations through CUREator+
Imugene doses the first patient in pioneering Phase 1 onCARlytics tria
How Cell Death Affects Your Health
New Biotech Company Tackles Hard-to-treat Cancers
Epitope Binning-seq: A Game-Changer in Antibody Drug Discovery Researchers pioneer a novel method, enabling simultaneous analysis of multiple antibodies, revolutionizing drug discovery…
Promising Role Of Antidiabetic Drug In Cancer Control
New Investment: Fight Against MND Continues
Key To Improving Cancer Treatments Discovered